RAD51 GENE MUTATION

Clinical trials for RAD51 GENE MUTATION explained in plain language.

Never miss a new study

Get alerted when new RAD51 GENE MUTATION trials appear

Sign up with your email to follow new studies for RAD51 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Terminated 1

Targeted drug olaparib tested in breast cancer patients with DNA repair flaws

Disease control Ongoing

This phase 2 study tests the drug olaparib in 114 people with metastatic breast cancer whose tumors have mutations in certain DNA repair genes (like BRCA1, BRCA2, ATM, PALB2, and others). Olaparib is a PARP inhibitor that may kill cancer cells by blocking their ability to fix dam…

Matched conditions: RAD51 GENE MUTATION

Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control

Last updated Jun 27, 2026 08:08 UTC

RAD51 GENE MUTATION

Get alerted when new RAD51 GENE MUTATION trials appear

Targeted drug olaparib tested in breast cancer patients with DNA repair flaws